Background:Background: The credibility of contingent valuation studies has been questioned because of the potential occurrence of scope insensitivity, i.e. that respondents do not react to higher quantities or qualities of a good. Abstract: Objective:Objective: The aim of this study was to...

Background:Background: National EQ-5D value sets are developed because preferences for health may vary in different populations. UK values are lower than US values for most of the 243 possible EQ-5D health states. Although similar protocols were used for data collection, analytic choices...

Background: In a previous article using population-level data, an a priori number-needed-to-decrease (NND) analysis was conducted to determine if there is potential opportunity in a given population for a disease management program to achieve financial effectiveness. Critics of that study have...

Background & Objective: In France, non-homeopathic general practitioners (GPs) often use antibacterials to treat children with recurrent acute viral rhinopharyngitis; whereas homeopathic GPs tend to use homeopathic medicines. We compared the effectiveness, the quality of life of the parents, and...

Introduction: Standard methods of economic analysis may not be suitable for local decision making that is specific to a particular population. Background: We describe a new three-step methodology, termed `population cost-impact analysis', which provides a population perspective to the costs and...

This paper reconsiders the evidence and several of the key arguments associated with the theory of supplier-induced demand (SID). It proposes a new theory to explain how ethical behaviour is consistent with SID. The purpose of a theory of demand and one criterion for the evaluation of a theory...

Parallel trade in pharmaceuticals has become a major European Union policy issue with several `solutions' being considered by the European Commission, Member State governments and the pharmaceutical industry in the `Bangemann Process'. This paper discusses the issues from an economic and public...

Objective: To assess the goals, strategic focus, structure, capabilities, activities and effectiveness of health economics (HE) departments in the Canadian pharmaceutical industry, to examine how these have evolved, and the implications of HE in the future of the pharmaceutical industry. Design...